Ohr制药(OHRP)
5.39 0.00 0.0%
| 今开：0.0 | 昨收：5.39 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.5249647E7 |
Ohr制药的最新讨论
![[俏皮]](https://assets.imedao.com/ugc/images/face/emoji_04_cool.png?v=1 "[俏皮]"){kind=small}
![[捂脸]](https://assets.imedao.com/ugc/images/face/emoji_33_face.png?v=1 "[捂脸]"){kind=small}
再涨也不是我的了chuminhua2019-01-03 23:08
$Ohr制药(OHRP)$
12/3，NeuBase Therapeutics通过反向收购Ohr Pharmaceutical，在纳斯达克上市。NeuBase的模块化反义肽核酸（PNA）平台PATrOL用于改善基因沉默疗法。网页链接查看全文
Ohr制药的公告
$OHR PHARMACEUTICAL INC(OHRP)$ 8-K - Current report Filed: 2016-12-15 AccNo: 0001387131-16-008482 Size: 40 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Filed: 2016-12-14 AccNo: 0001387131-16-008477 Size: 27 KB 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2016-12-09 AccNo: 0001387131-16-008415 Size: 677 KB 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ 8-K - Current report Filed: 2016-12-08 AccNo: 0001387131-16-008408 Size: 577 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2016-12-07 AccNo: 0001387131-16-008390 Size: 674 KB 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ 10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2016-12-07 AccNo: 0001387131-16-008387 Size: 38 KB 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ 8-K - Current report Filed: 2016-08-12 AccNo: 0001387131-16-006492 Size: 239 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-08-09 AccNo: 0001387131-16-006411 Size: 2 MB 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ 美东时间 2016-08-09 16:30 After Market Close:OHR PHARMACEUT Earning Release . Wall St EPS Est ($):-0.23. 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2016-08-02 AccNo: 0001387131-16-006273 Size: 56 KB 网页链接